Waiting for the next wave...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
If we finish at $0.04 my whole account becomes green on this down day...
bullshit - it should be $0.36
bullshit
we can close at $0.0450 today...
One thing for sure - ELTP has more potential than PFE
Buy in the dip...
Go Elite GO -
0.0401...
Nasrat buying some stock with Xmas money...
I would like to make a correction to my previous post.
Dexcell is in teh Adderall market for a while apparently - there is also a Lannett/Dexcel connection our there. I saw a SEC filing from Lannett where Dexcel was mentioned.
It was too late and on my phone - I will check that again.
Dexcel applied for adderall xr anda in September 2021.
https://www.fda.gov/media/71502/download
Nasrat has made Elite profitable.
Nasrat has created a new pipeline.
Nasrat has created partnerships.
Nasrat is funding some new developments from his own money and without dilution
Nasrat has avoided Elite to be sued in the Opioid debacle (See Teva who was found guilty last Friday of December)
"there are no such talks lol lol"
Prove it !!!
Pfizer cancelled the year end party to try to finalize the deal...
But there is a lot to talk about so I guess it will continue in 2022...
Waiting…. Dr. What do u have to say
Exactly!!! Nothing bad to say.
Normal trading day
It appears Teva was just found guilty in an opioid trial for pushing them in New York.
Amount to be decided.
Just fyi
Agree - the recording says Loxapine ...
Weezuhl. You solved the puzzle!!!
Nasrat dropped news by mistake.
He is working on Prozac generic it is the first time ever he names that molecule.
This makes sense approval in Q1 2022. Partnership with the guys who will market loxapine in June 2022
PROZAC Generic!!! Hey the table needs to be updated with Fluoxetine capsules launched in June.
From the transcript:
So 2022 we have a product under review with FDA. We have a licensed product co-developed with a partner that we are expecting approval in the first half of this coming year 2022. For our commercial products, Fluoxetine capsules are launched in June and they are marketed by Cresco under their Burrell Pharmaceutical label. Fluoxetine continues to be on the FDAs product shortage list. And we are expecting further growth from this product.
The company is profitable.
The ceo has some good moves that will increase revenue.
If I was you I would wait as the upside is huge from 3 cents
Site is up
Thanks N2K for the great analysis as always.
I also believe 2022 will be a great year with a chance to move to the Nasdaq if there is a sufficient penetration of Adderall XR, KVK drugs replacement, EPIC marketing penetration, Big name ANDA with few competitors, Dexcel in Israel and more countries after that, a partnership with a big pharma like PFE and mostly an attempt at having our own Product with a brand new NDA.
If all the above realizes itself, we could see much higher sales maybe in the $50 Mil in 2022.
Elite has $9.6 million in cash
Turning over to our balance sheet, our working capital continues to grow to $9.6 million, up $3.2 million from year-end. This is directly due to positive cash flow from operations and low debt. To sum it up with higher sales and a strong margin, we continue to beat last year numbers and with that, I'd like to turn it back to Nasrat to give an overview on the company.
Walgreens is second biggest pharmacy after CVS - Let's get CVS too
How much sales and profit will it take for investors to see Elite for what it is?
$50 Mil? $100 Mil? $200 Mil?
On our way there - quicker than you think....
When the stars align...
I wonder what happened to the drugs KVK could not provide. How much of it did we get?
The old wolf has a vision...
Dexcel, Lannett XR at Walgreens, ANDA's of drugs with few competitors, growing the PPS until it explodes because one day it will be way too much undervalued...
Is there any way to know how much elite adderall xr walgreen has in inventory?
$0.04 is reachable today.
If it is the Sungen one then it is Huge.
I do not think he was referring to SequestOx That would be against all what he claimed so far - unless he is going for the idea I shared with Dianne to have SequestOx approved and sell it while keeping the manufacturing in house
Does anyone know what product was filed and expected to be approved in Q1/Q2?
"The answer is yes, we are doing well and on target. We have a product that's filed and we expect approval in Q1, Q2 of next year. We have multiple products at different stages of development, couple of that will be ready for clinical trials within the first half of next year and a couple will do them probably during the second half, part of it be the formulations will be more ready and part of it also financial. We also have other development products at the formulation and stability stage."
Catalysts for this quarter: Adderall XR being sold at Walgreens, Drugs moved to EPIC are being sold, Dexcel Agreement, the KVB debacle - we may have been able to replace them in some accounts...
Remind me please if there are more catalysts...
-------------------
From Teleconference:
:Isradipine and Trimipramine, Epic is our partner for these two products. They are interesting products because they have very limited competition. Epic is still in the transition phase. And hopefully by the end of this year, they will be done and we'll start to see a little more profits and revenues from these products."
They must have a non competition clause
I wonder why Lannett did not have a pr for their adderall fda approval last month.
Aelmtpa. No one really knows if Nasrat had accounted for the xr at Walgreens. I am just saying that xr found its way pretty late to the Walgreens shelves in the quarter.
Knowing Nasrat for years, he may have not counted on xr sales at Walgreens to be part of the q.
Noticing a huge price difference between USA and israel.
$17 for 100 capsules in the USA. $800 in israel.
Hence the floor price and profit split
We were in the middle of the quarter when he said that. Enough time to get the orders in, production and shipping.
Just saying this is a big client. Adderall xr is more expensive than ir. Demand is much higher than Ir.
12 mil is conservative